You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

p53 reactivator

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pediatric Cancer, Li-Fraumeni Syndrome, p53 Mutations Trial in Guangzhou (Arsenic trioxide)

Not yet recruiting
  • Pediatric Cancer
  • +2 more
  • Arsenic trioxide
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Oct 12, 2023

Relapsing-remitting Multiple Sclerosis Trial (CT-P53, US-Ocrevus, EU-Ocrevus)

Not yet recruiting
  • Relapsing-remitting Multiple Sclerosis
  • CT-P53
  • +2 more
  • (no location specified)
Jun 7, 2023

Advanced Solid Tumor, Advanced Malignant Tumor, Metastatic Cancer Trial in United States (PC14586)

Recruiting
  • Advanced Solid Tumor
  • +3 more
  • Los Angeles, California
  • +10 more
Aug 12, 2022

SNPs in p53 and p53 Response Elements on Inflammatory Response

Completed
  • HIV-1 Seropositive
  • +3 more
    • Research Triangle Park, North Carolina
      NIEHS Clinical Research Unit (CRU)
    Jan 21, 2023

    P53 Immunohistochemistry Abnormal Staining in Endometrial Cancer

    Completed
    • Endometrial Cancer
    • p 53 immunohistochemistry positive staining and relation to stages ,pathological types and grading
    • Alexandria, Egypt
      Hossam Hassan El Sokkary
    Sep 13, 2022

    Diffuse Large B Cell Lymphoma Trial in Wuhan (Zanubrutinib plus RCHOP)

    Recruiting
    • Diffuse Large B Cell Lymphoma
    • Zanubrutinib plus RCHOP
    • Wuhan, Hubei, China
      Union Hospital, Tongji Medical College, Huazhong University of S
    Aug 16, 2023

    Infiltrating Duct Carcinoma of the Breast

    Not yet recruiting
    • Invasive Breast Cancer
      • (no location specified)
      Jan 28, 2023

      Endometrial Cancer Trial (Vaginal brachytherapy, Adjuvant radiotherapy (EBRT +/- brachytherapy), Observation)

      Not yet recruiting
      • Endometrial Cancer
      • Vaginal brachytherapy
      • +2 more
      • (no location specified)
      Nov 29, 2022

      Multiple Myeloma Trial in Tianjin (anti-BCMA CAR-T, Selinexor-VRD)

      Recruiting
      • Multiple Myeloma
      • Tianjin, China
        Institute of Hematology and Blood Diseases Hospital Chinese Acad
      May 12, 2023

      Unusual Infiltrative Patterns of Malignant Cells in Endometrial

      Not yet recruiting
      • Endometrial Cancer
        • (no location specified)
        Mar 11, 2023

        Secondary Obliteration of Old Radical Cavities Using S53P4

        Recruiting
        • Mastoid Cavity
        • S53P4 bioactive glass granules
        • Utrecht, Netherlands
          Diakonessenhuis
        Nov 1, 2023

        Endometrial Cancer Trial (Paclitaxel, Carboplatin, Cisplatin)

        Not yet recruiting
        • Endometrial Cancer
        • (no location specified)
        Aug 4, 2022

        Locally Advanced Cervical Cancer Trial in Mexico City (Curcumin, Curcumin + Piperine)

        Recruiting
        • Locally Advanced Cervical Cancer
        • Curcumin
        • Curcumin + Piperine
        • Mexico City, Mexico
          Instituto Nacional de Cancerología
        Oct 6, 2023

        DLBCL Trial in Qingdao (Selinexor combined with Prednisone, Etoposide, and Lenalidomide)

        Not yet recruiting
        • DLBCL
        • Selinexor combined with Prednisone, Etoposide, and Lenalidomide
        • Qingdao, Shandong, China
          the affiliated hospital of Qingdao University
        Aug 18, 2022

        Vulvar Cancer Trial in Vancouver (Re-excision)

        Not yet recruiting
        • Vulvar Cancer
        • Re-excision
        • Vancouver, British Columbia, Canada
          BC Cancer - Vancouver Centre
        Oct 8, 2022

        Advanced Cancers Trial in Houston (MLN9708, Vorinostat)

        Completed
        • Advanced Cancers
        • Houston, Texas
          University of Texas MD Anderson Cancer Center
        Jul 8, 2022

        DLBCL Trial (Sintilimab, Rituximab)

        Not yet recruiting
        • Diffuse Large B-Cell Lymphoma
        • (no location specified)
        Mar 6, 2022

        Endometrial Cancer Trial in Vancouver (Treatment de-escalation)

        Recruiting
        • Endometrial Cancer
        • Treatment de-escalation
        • Vancouver, British Columbia, Canada
          BC Cancer - Vancouver Centre
        Mar 1, 2022

        Endometrial Cancer Trial in Israel, United States (Selinexor, Matching Placebo for selinexor)

        Recruiting
        • Endometrial Cancer
        • Miami Beach, Florida
        • +6 more
        Jan 31, 2023

        Endometrial Cancer Trial in Worldwide (drug, radiation, other)

        Recruiting
        • Endometrial Cancer
        • Toronto, Canada
        • +5 more
        Jul 12, 2022

        p53 Gene in Metabolism Regulation in Li-Fraumeni Syndrome

        Completed
        • Mitochondrial Disorders
        • +2 more
          • Bethesda, Maryland
            National Institutes of Health Clinical Center, 9000 Rockville Pi
          Nov 18, 2021

          Advanced Soft-tissue Sarcoma, Metastatic Soft-tissue Sarcoma Trial in France (Pazopanib, HDM201)

          Recruiting
          • Advanced Soft-tissue Sarcoma
          • Metastatic Soft-tissue Sarcoma
          • Bordeaux, France
          • +4 more
          May 5, 2022

          p53 and Response to Preoperative Radiotherapy for T2 and T3

          Recruiting
          • Rectal Cancer
          • preoperative short course radiation
          • Vienna, Austria
            Medical University of Vienna, Department of Surgery
          Apr 6, 2022

          Epithelial Ovarian Cancer Trial in Amsterdam (MK-1775 and carboplatin)

          Active, not recruiting
          • Epithelial Ovarian Cancer
          • MK-1775 and carboplatin
          • Amsterdam, Netherlands
            Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital
          Dec 21, 2021

          Short- and Medium-term Evaluation of Mastoid Filling Using

          Not yet recruiting
          • Cholesteatoma
          • verre bioactif 45S5 GlassBONE
          • verre bioactif S53P4 Bonalive
          • Lyon, Pierre-Bénite, France
            Hôpital Lyon Sud
          Jun 16, 2023